Anastasia Andreas graduated as a Food Chemist from the University of Hohenheim in 2012 (undergraduate studies in Chemistry at the University of Stuttgart). Her diploma thesis topic was the development of a method for culture independent analysis of microbial biodiversity on the surface of lettuce plants. After completing the studies, Anastasia worked on a project with HBV, HCV and HIV at Roche Molecular Diagnostics in Rotkreuz, Switzerland and later at the University of Luxembourg in the Luxembourg Centre for Systems Biomedicine (LCSB). Here, she was performing screenings on zebrafish embryos to discover new potential antiepileptic drug candidates and was responsible for operation of the animal facility.
Since 2017, Anastasia is working at the Helmholtz Institute for Pharmaceutical Research Saarland on her PhD project in the group of Microbial Natural Products. Her project focus lies on the elucidation of the mechanism of action of chlorotonils, a group of highly antibacterial active macrolides derived from microbial secondary metabolites. Additionally, she is involved in the management of the zebrafish facility at HIPS and uses zebrafish larvae to evaluate compound toxicity and to establish zebrafish infection models.